Unit 3: Drugs and Society

Answer: A — Option A is correct because educational programs have been shown to be effective in preventing drug abuse by teaching children about the risks associated with drug use. Option B is incorrect because while treatment centers are necessary for those already struggling with addiction, they do not address the root cause of prevention. Option C is incorrect because relying solely on law enforcement can lead to increased criminalization without addressing the underlying issues of addiction. Option D is incorrect because ignoring the issue will not lead to any positive change or reduction in drug abuse.

Answer: A — The correct answer (A) reflects the clinical distinction between use and abuse: substance abuse is defined by harmful consequences and functional impairment, not merely by frequency or the substance itself. This teaches the key concept that abuse involves a maladaptive pattern causing real-world problems. Option B represents the misconception that frequency alone determines abuse—many people drink regularly without abuse. Option C incorrectly suggests any use equals abuse, ignoring the harm/impairment criterion central to diagnosis. Option D falsely claims substance type determines abuse classification and wrongly implies alcohol cannot cause abuse, contradicting evidence of alcohol-related disorders.

Answer: A — CORRECT (A): Epidemiological reasoning requires controlling for exposure/prevalence. Alcohol has significantly higher usage rates and legal accessibility than marijuana, so comparing raw ER visit numbers without adjusting for number of users creates a confounding variable. A substance used by millions daily might generate more visits than one used by fewer people, even if per-user risk differs. This tests understanding of how to critically evaluate drug harm data in society. WIRONG (B): Reflects misconception that legal/illegal status determines research validity. Legal substances can and should be studied for health impacts using the same rigorous methods as illegal drugs. This ignores that epidemiological data quality is independent of legal status. WRONG (C): Misrepresents user agency and confuses voluntary use with safety. While legal availability affects usage patterns, this doesn't invalidate harm comparisons. Both substances are used by choice in many cases, and involuntary use doesn't determine a drug's inherent danger profile. WRONG (D): Confuses drug scheduling with actual harm. Schedule I classification is based on legal/regulatory criteria, not empirical danger ranking. This misconception ignores that scheduling reflects policy decisions rather than objective harm assessment relative to other substances.

Answer: C — The correct answer identifies pharmacokinetics and genetic variation in drug metabolism as the explanation. Patient A's increased liver enzyme activity means faster metabolism and elimination of the drug, resulting in lower circulating drug levels and thus fewer side effects. Patient B's normal enzyme activity means slower metabolism, higher drug accumulation, and more pronounced effects. This tests application of the concept that individual differences in drug response stem from metabolic factors. Option A incorrectly suggests tolerance (a neurobiological adaptation requiring repeated use), which doesn't explain initial differences. Option B represents a misconception that psychological factors rather than physiological pharmacology drive these differential responses. Option D suggests pharmaceutical differences rather than patient-level biological variation, missing the core concept of individual pharmacogenetic variation.

Answer: D — The correct answer (D) reflects a sophisticated understanding that societal harms from substance abuse are driven primarily by underlying social and structural factors rather than the drugs themselves. The social determinants framework explains why diverse communities with similar disadvantages experience comparable dysfunction patterns, even when substance preferences differ. This tests application of ecological/systems thinking. Option A confuses the gateway hypothesis (a sequential addiction pattern theory) with explanation of uniform societal consequences—the gateway hypothesis actually predicts different outcomes based on progression. Option B misunderstands pharmacology and epidemiology; alcohol's prevalence doesn't explain uniform harms across communities using different primary substances. Option C, while partially true, describes individual-level dysfunction without addressing why community-level patterns are consistent across drug types—it lacks the sociological depth needed to fully explain the researcher's observation. The question requires understanding that drug choice is contextual/environmental rather than deterministic of outcome severity.